These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 2529025)
21. Biological significance of gene amplification in carcinogenesis. Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251 [TBL] [Abstract][Full Text] [Related]
22. [The intensity of hst-1 gene amplification and malignant potential of esophageal carcinoma in relation to intratumoral heterogeneity]. Chikuba K; Saito T; Kaketani K; Uchino S; Sato K; Shimoda K; Miyahara M; Kobayashi M Gan To Kagaku Ryoho; 1993 Apr; 20(6):763-6. PubMed ID: 8489282 [TBL] [Abstract][Full Text] [Related]
23. Expression of int-2 mRNA in human tumors amplified at the int-2 locus. Liscia DS; Merlo GR; Garrett C; French D; Mariani-Costantini R; Callahan R Oncogene; 1989 Oct; 4(10):1219-24. PubMed ID: 2677918 [TBL] [Abstract][Full Text] [Related]
24. Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Theillet C; Le Roy X; De Lapeyrière O; Grosgeorges J; Adnane J; Raynaud SD; Simony-Lafontaine J; Goldfarb M; Escot C; Birnbaum D Oncogene; 1989 Jul; 4(7):915-22. PubMed ID: 2474139 [TBL] [Abstract][Full Text] [Related]
25. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Nishida N; Fukuda Y; Komeda T; Kita R; Sando T; Furukawa M; Amenomori M; Shibagaki I; Nakao K; Ikenaga M Cancer Res; 1994 Jun; 54(12):3107-10. PubMed ID: 8205525 [TBL] [Abstract][Full Text] [Related]
26. Molecular biology of the hst-1 gene. Sugimura T; Yoshida T; Sakamoto H; Katoh O; Hattori Y; Terada M Ciba Found Symp; 1990; 150():79-89; discussion 89-98. PubMed ID: 2142645 [TBL] [Abstract][Full Text] [Related]
27. Coamplification of the hst-1 and int-2 genes in human cancers. Tsutsumi M; Sakamoto H; Yoshida T; Kakizoe T; Koiso K; Sugimura T; Terada M Jpn J Cancer Res; 1988 Apr; 79(4):428-32. PubMed ID: 3133332 [TBL] [Abstract][Full Text] [Related]
28. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Muller D; Millon R; Lidereau R; Engelmann A; Bronner G; Flesch H; Eber M; Methlin G; Abecassis J Eur J Cancer B Oral Oncol; 1994; 30B(2):113-20. PubMed ID: 8032300 [TBL] [Abstract][Full Text] [Related]
29. Proto-oncogene amplification and human breast tumor phenotype. Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239 [TBL] [Abstract][Full Text] [Related]
30. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Tsuda H; Fukutomi T; Hirohashi S Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981 [TBL] [Abstract][Full Text] [Related]
31. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables. Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K; Terada K; Sugiyama T Cancer Invest; 1997; 15(5):411-5. PubMed ID: 9316622 [TBL] [Abstract][Full Text] [Related]
32. The FGF-related oncogenes hst and int.2, and the bcl.1 locus are contained within one megabase in band q13 of chromosome 11, while the fgf.5 oncogene maps to 4q21. Nguyen C; Roux D; Mattei MG; de Lapeyriere O; Goldfarb M; Birnbaum D; Jordan BR Oncogene; 1988 Dec; 3(6):703-8. PubMed ID: 2577873 [TBL] [Abstract][Full Text] [Related]
33. Amplification of the hst-1 gene in human esophageal carcinomas. Tsuda T; Nakatani H; Matsumura T; Yoshida K; Tahara E; Nishihira T; Sakamoto H; Yoshida T; Terada M; Sugimura T Jpn J Cancer Res; 1988 May; 79(5):584-8. PubMed ID: 3136110 [TBL] [Abstract][Full Text] [Related]
34. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer. Champème MH; Bièche I; Hacène K; Lidereau R Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157 [TBL] [Abstract][Full Text] [Related]
35. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415 [TBL] [Abstract][Full Text] [Related]
36. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas. Tsuruta H; Sakamoto H; Onda M; Terada M Biochem Biophys Res Commun; 1993 Nov; 196(3):1529-36. PubMed ID: 8250909 [TBL] [Abstract][Full Text] [Related]
38. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors. Yuan B; Oechsli MN; Hendler FJ Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609 [TBL] [Abstract][Full Text] [Related]
39. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. Gaffey MJ; Frierson HF; Williams ME Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628 [TBL] [Abstract][Full Text] [Related]
40. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]